达芬奇Xi系统在完全机器人根治性远端胃大部切除术中的应用

doi:10.6040/j.issn.1671-7554.0.2020.351

摘要/Abstract

摘要： 目的探讨达芬奇Xi系统应用于完全机器人根治性远端胃大部切除术的安全性和可行性。方法回顾性分析江志伟团队自2017年10月至2020年2月收治的完全达芬奇机器人根治性远端胃大部切除术患者的临床资料。所有患者淋巴结清扫和消化道重建均在镜下完成。其中采用达芬奇S系统行根治性远端胃大部切除手术患者63例(S系统组),采用达芬奇Xi系统行根治性远端胃大部切除手术患者39例(Xi系统组)。观察分析两组患者手术情况、术后恢复情况及术后并发症发生率。结果 102例患者均成功完成完全机器人根治性远端胃大部切除手术,无中转开腹患者。Xi系统组与S系统组患者术中出血量［(69.1± 43.2)mL vs(84.2± 48.9)mL,P=0.091］、淋巴结清扫数目［(31.4±8.9)枚vs(32.4±9.4)枚,P=0.357］差异无统计学意义。Xi系统组装机时间［(5.1±1.9)min vs(11.2±3.7)min, P<0.001］、手术时间［(206.2±45.3)min vs(221.5±42.3)min, P=0.013］短于S系统组;Xi系统组术中擦镜次数明显少于S系统组［(4.3±1.6)次 vs(12.2±4.9)次,P<0.001］。两组患者术后恢复情况(术后首次下床活动时间、术后耐受半流质饮食时间、术后首次通气时间)差异无统计学意义,两组术后住院时间和并发症发生率差异无统计学意义。结论达芬奇系统应用于根治性远端胃大部切除术是安全可行的,可以利用其优势完成缝合、打结等精细操作,新一代达芬奇机器人Xi系统利用其更佳的80°内窥镜可视范围、更加灵活的机械臂,以及悬吊式平台,显著节省了手术时间。

关键词: 胃肿瘤, 达芬奇机器人系统, 根治性远端胃切除

Abstract: Objective To investigate the safety and feasibility of Da Vinci Xi robotic surgical system in full robotic radical distal gastrectomy. Methods The clinical data of patients treated with Da Vinci robotic surgical system in full radical distal gastrectomy by Jiang Zhiweis team during Oct. 2017 and Feb. 2020 were retrospectively analyzed. Lymph node dissection and digestive tract reconstruction were performed under microscope in all patients. Radical distal gastrectomy with Da Vinci S system was performed in 63 patients(S system group), and radical distal gastrectomy with Da Vinci Xi system was performed in 39 patients(Xi system group). The operation situation, postoperative recovery and complications were recorded. Results All operations were successful, with no conversion to open surgery. There were no significant differences in intraoperative blood loss ［(69.1±43.2)mL vs(84.2±48.9)mL, P=0.091］ and number of lymph node dissection ［(31.4±8.9)vs(32.4±9.4), P=0.357］ between Xi system group and S system group. Xi system had significantly shorter machine assembly time ［(5.1±1.9)min vs(11.2±3.7)min, P<0.001］, shorter operation time ［(206.2±45.3)min vs(221.5±42.3)min, P=0.013］, and lower intraoperative lens cleaning frequency ［(4.3±1.6)times vs(12.2±4.9)times, P<0.001］ than S system. There were no significant differences in time to first off-bed activity, time to recover semiliquid diet, time to first flatus, postoperative length of stay and incidence of complications between the two groups. Conclusion The Da Vinci system is safe and feasible for radical distal gastrectomy, and can be used to perform accurate surgical manipulations such as suture and knotting. The new Da Vinci robotic Xi system has a better endoscope view of 80°, more flexible robotic arm and a suspended platform, which can significantly save surgical time.

Key words: Gastric neoplasms, Da Vinci robotic surgical system, Radical distal gastrectomy

中图分类号:

王刚,潘华峰,刘江,王海峰,程伟,江志伟. 达芬奇Xi系统在完全机器人根治性远端胃大部切除术中的应用[J]. 山东大学学报 (医学版), 2020, 58(5): 51-55.

WANG Gang, PAN Huafeng, LIU Jiang, WANG Haifeng, CHENG Wei, JIANG Zhiwei. Application of Da Vinci Xi robotic surgical system in full robotic radical distal gastrectomy[J]. Journal of Shandong University (Health Sciences), 2020, 58(5): 51-55.

参考文献

[1] Huscher CG, Mingoli A, Sgarzini G, et al. Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial [J]. Ann Surg, 2005, 241(2): 232-237.
[2] Kim HH, Hyung WJ, Cho GS, et al. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report-a phase III multicenter, prospective, randomized Trial(KLASS Trial)[J]. Ann Surg, 2010, 251(3): 417-420.
[3] Kitano S, Shiraishi N, Fujii K, et al. A randomized controlled trial comparing open vs laparoscopy-assisted distal gastrectomy for the treatment of early gastric cancer: an interim report [J]. Surgery, 2002, 131(1 Suppl): S306-S311.
[4] Hu Y, Huang C, Sun Y, et al. Morbidity and mortality of laparoscopic versus open D2 distal gastrectomy for advanced gastric cancer:a randomized controlled trial [J]. J Clin Oncol, 2016, 34(12): 1350-1357.
[5] Chen D, Chen G, Jiang W, et al. Association of the collagen signature in the tumor microenvironment with lymph node metastasis in early gastric cancer [J]. JAMA Surgery, 2019, 154(3): e185249.doi: 10.1001/jamasurg.2018.5249.
[6] Hashizume M, Shimada M, Tomikawa M, et al. Early experiences of endoscopic procedures in general surgery assisted by a computer-enhanced surgical system [J]. Surg Endosc, 2002, 16(8): 1187-1191.
[7] Quijano Y, Vicente E, Ielpo B, et al. Full robot-assisted gastrectomy:surgical technique and preliminary experience from a single center [J]. J Robot Surg, 2016, 10(4): 297-306.
[8] Son T, Lee JH, Kim YM, et al. Robotic spleen-preserving total gastrectomy for gastric cancer: comparison with conventional laparoscopic procedure [J]. Surg Endosc, 2014, 28(9): 2606-2615.
[9] Yoon HM, Kim YW, Lee JH, et al. Robot-assisted total gastrectomy is comparable with laparoscopically assisted total gastrectomy for early gastric cancer [J]. Surg Endosc, 2012, 26(5): 1377-1381.
[10] Yang SY, Roh KH, Kim YN, et al. Surgical Outcomes After Open, Laparoseopie, and Robotic Gastrectomy for Gastric Cancer [J]. Ann Surg Oncol, 2017, 24(7): 1770-1777.
[11] Song J, Oh SJ, Kang WH, et al. Robot-assisted gastrectomy with lymph node dissection for gastric cancer: lessons learned from an initial 100 consecutive procedures [J]. Ann Surg, 2009, 249(6): 927-932.
[12] 江志伟, 赵坤, 王刚, 等. 应用手术机器人系统行食管空肠吻合的可行性观察[J]. 中国实用外科杂志, 2012, 32(8): 641-643. JIANG Zhiwei, ZHAO Kun, WANG Gang, et al. Reconstruction of esophagojejunostomy by robot-sewing technique in totally robotic total gastrectomy [J]. Chinese Journal of Practical Surgery, 2012, 32(8): 641-643.
[13] Wang G, Jiang ZW, Zhao J, et al. Assessing the safety and efficacy of full robotic gastrectomy with intracorporeal robot-sewn anastomosis for gastric cancer: A randomized clinical trial [J]. J Surg Oncol, 2016, 113(4): 397-404.
[14] 胡祥. 第十四版日本《胃癌处理规约》的重要变更[J]. 中国实用外科杂志, 2010, 30(4): 241-246.
[15] Gosrisirikul C, Don Chang K, Raheem AA, et al. New era of robotic surgical systems [J]. Asian J Endose Surg, 2018, 11(4): 291-299.
[16] 刘驰, 唐波, 郝迎学, 等. 达芬奇机器人与腹腔镜胃癌手术近期疗效的对照研究 [J]. 第三军医大学学报, 2013, 35(11): 1164-1166. LIU Chi, TANG Bo, HAO Yingxue, et al. Surgical short-term outcomes of robotic gastrectomy versus laparoscopic gastrectomy: a case-control study[J]. Journal of Third Military Medical University, 2013, 35(11): 1164-1166.
[17] Pugliese R, Maggioni D, Sansonna F, et al. Subtotal gastrectomy with D2 dissection by minimally invasive surgery for distal adenocarcinoma of the stomach: results and 5-year survival [J]. Surg Endosc, 2010, 24(10): 2594-2602.
[18] Coratti A, Femandes E, Lombardi A, et al. Robot-assisted surgery for gastric carcinoma: Five years follow-up and beyond: a single western center experience and long-term oncological outcomes [J]. Eur J Surg Oncol, 2015, 41(8): 1106-1113.
[19] Rodriguez-Sanjuan JC, Gomez-Ruiz M, Trugeda-Carrera S, et al. Laparoscopic and robot-assisted laparoscopic digestive surgery: present and future directions [J]. World J gastmenterol, 2016, 22(6): 1975-2004.
[20] 郝迎学, 刘春阳, 冯晨, 等. 完全达芬奇机器人手术系统胃癌根治术的临床疗效[J]. 中华消化外科杂志, 2017, 16(10): 1067-1071. HAO Yingxue, LIU Chunyang, FENG Chen, et al. Clinical efficacy of totally Da Vinci robotic surgical system in radical gastrectomy of gastric cancer[J]. Chinese Journal of Digestive Surgery, 2017, 16(10): 1067-1071.
[21] 赵健, 王刚, 江志伟. 机器人胃癌手术镜下吻合技术[J]. 中国普外基础与临床杂志, 2017, 24(4): 410-411. ZHAO Jian, WANG Gang, JIANG Zhiwei, et al. Robotic anastomosis technique for gastric cancer [J]. Chinese Journal of Bases and Clinics in General Surgery, 2017, 24(4): 410-411.

相关文章 15

[1]	张婷婷,王刚,徐昌霞,刘江,支梦伟,江志伟. 3D腹腔镜胃血管球瘤切除术报道1例[J]. 山东大学学报 (医学版), 2019, 57(12): 110-113.
[2]	底学敏,牛书雷,赵静,杜随,于慧敏,张宏涛,王娟. CT引导下¹²⁵I粒子植入治疗晚期胃癌淋巴结转移[J]. 山东大学学报（医学版）, 2017, 55(9): 79-84.
[3]	聂思月,王震,孙靖宇,刘杰,李娟,魏小娟,路春晓,吕兴龑,王淑云,孙玉萍. ANGPTL5在人胃癌组织中的表达及临床意义[J]. 山东大学学报（医学版）, 2017, 55(8): 61-65.
[4]	丁娟, 郑桂喜, 杜鲁涛, 尹作花, 张建, 王传新. 外周血sHLA-G与PGR、GPR联合检测在胃癌诊断中的效能评估[J]. 山东大学学报（医学版）, 2015, 53(11): 59-63.
[5]	张诤, 申洪昌, 付国斌, 张建超, 王潍博. GRK6在胃癌中的表达及其预后价值[J]. 山东大学学报（医学版）, 2014, 52(7): 50-55.
[6]	连海峰, 李明, 刘成霞, 贾兴芳, 李丹. NRP2在胃癌中的表达及其临床意义[J]. 山东大学学报（医学版）, 2014, 52(7): 56-59.
[7]	胡瑞1,郏雁飞2，郑燕2，马晓丽2，孔毅1，黎娉1,汪运山2. 缺氧对人胃癌细胞HIF-1α及DEC1表达的影响[J]. 山东大学学报（医学版）, 2014, 52(4): 35-38.
[8]	王晓蕾1,郏雁飞2,郑燕2,刘华2,汪运山2. STAT3真核表达质粒的构建及对胃癌细胞增殖的影响[J]. 山东大学学报(医学版), 2013, 51(9): 45-49.
[9]	王臣臣1，顾晓萌1，王妍2，黄山英3 . TFF3在胃癌、癌前病变中的表达及与血管生成的关系[J]. 山东大学学报(医学版), 2013, 51(2): 99-103.
[10]	刘海燕1，李陪2，高辉3，朱长军2，董智雄2. 染色体驱动蛋白KIF4A对胃癌细胞迁移和转移的影响[J]. 山东大学学报(医学版), 2013, 51(12): 25-28.
[11]	杜宪红1，邢召全2，焦晋山1. miR-200c在CIK细胞诱导胃癌细胞凋亡中的作用[J]. 山东大学学报(医学版), 2013, 51(06): 49-52.
[12]	戴新1,郑燕2，郏雁飞2，肖东杰2，童书青1，汪运山2. EC1基因真核表达质粒的构建及对胃癌细胞增殖的影响[J]. 山东大学学报(医学版), 2012, 50(6): 75-.
[13]	陈宗营. HGC-1在胃癌中的表达及其与胃癌临床病理学因素和预后的关系[J]. 山东大学学报(医学版), 2012, 50(4): 87-.
[14]	张江洲1，卢小开2，冯志宇2，龙志雄1，冉立3，谭诗生2. 胃癌术后放疗三种放疗技术的剂量学比较研究[J]. 山东大学学报(医学版), 2012, 50(2): 64-69.
[15]	尹作花1，王立水1，张欣1，张旭华2，王玎1，董召刚1，王丽丽1，王顺2，杜鲁涛1，李娟1，刘慧1，王传新1. 抑酸药对胃蛋白酶原和胃泌素17诊断胃癌的影响[J]. 山东大学学报(医学版), 2012, 50(2): 70-.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed